Full Product Name
Anti-LRP5 Mouse mAb
Product Synonym Names
HBM; LR3; OPS; EVR1; EVR4; LRP7; OPPG; BMND1; OPTA1; VBCH2
Product Gene Name
anti-LRP5 antibody
[Similar Products]
Product Synonym Gene Name
HBM; LR3; OPS; EVR1; EVR4; LRP7; OPPG; BMND1; OPTA1; VBCH2[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for O75197
Form/Format
Purified antibody in PBS with 0.05% sodium azide and 0.5% protein stabilizer;
Immunogen
Purified recombinant fragment of human LRP5 expressed in E Coli.
Other Notes
Small volumes of anti-LRP5 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-LRP5 antibody
Entrez Summary: This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy.
Applications Tested/Suitable for anti-LRP5 antibody
Western Blot (WB), Flow Cytometry (FC/FACS)
Western Blot (WB) of anti-LRP5 antibody
Western blot analysis using LRP5 mAb against human LRP5 (AA

Flow Cytometry (FC/FACS) of anti-LRP5 antibody
Flow cytometric analysis of HeLa cells using LRP5 mouse mAb (green) and negative control (red).

NCBI/Uniprot data below describe general gene information for LRP5. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001278831.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001291902.1
[Other Products]
UniProt Primary Accession #
O75197
[Other Products]
UniProt Secondary Accession #
Q96TD6; Q9UES7; Q9UP66[Other Products]
UniProt Related Accession #
O75197[Other Products]
NCBI Official Full Name
low-density lipoprotein receptor-related protein 5 isoform 2
NCBI Official Synonym Full Names
LDL receptor related protein 5
NCBI Official Symbol
LRP5??[Similar Products]
NCBI Official Synonym Symbols
HBM; LR3; OPS; EVR1; EVR4; LRP7; OPPG; BMND1; LRP-5; OPTA1; VBCH2
??[Similar Products]
NCBI Protein Information
low-density lipoprotein receptor-related protein 5
UniProt Protein Name
Low-density lipoprotein receptor-related protein 5
Protein Family
Low-density lipoprotein receptor-related protein
UniProt Gene Name
LRP5??[Similar Products]
UniProt Synonym Gene Names
LR3; LRP7; LRP-5??[Similar Products]
NCBI Summary for LRP5
This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
UniProt Comments for LRP5
LRP5: Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor- ligand complexes into ribosome-sized signalsomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalsomes and inhibiting AXIN1/GSK3- mediated phosphorylation and destruction of beta-catenin. Appears be required for postnatal control of vascular regression in the eye. Required for posterior patterning of the epiblast during gastrulation. Homodimer; disulfide-linked. Forms phosphorylated oligomer aggregates on Wnt-signaling. Component of a Wnt-signaling complex that contains a WNT protein, a FZD protein and LRP5 or LRP6. Interacts with FZD8; the interaction is formed on WNT-binding and signaling. Interacts (via the phosphorylated PPPSP motif domains) with AXIN1; the interaction prevents inhibition of beta-catenin phosphorylation and signaling and is enhanced in the presence of GSK3B and WNT1 or WNT3A. Interacts (via beta-propeller regions 3 and 4) with DKK1; the interaction, enhanced by MESD and/or KREMEN, inhibits beta-catenin signaling by preventing GSK3-mediated phosphorylation of the PPPSP motifs and subsequent, AXIN1 binding. Interacts with MESD; the interaction prevents the formation of LRP5 aggregates, targets LRP5 to the plasma membrane and, when complexed with KREMEN2, increases DKK1 binding. Interacts with CSNK1E. Interacts with SOST; the interaction antagonizes canonical Wnt signaling. Interacts with APCDD1. Widely expressed, with the highest level of expression in the liver and in aorta. Belongs to the LDLR family.
Protein type: Membrane protein, integral; Receptor, misc.
Chromosomal Location of Human Ortholog: 11q13.2
Cellular Component: plasma membrane; receptor complex
Molecular Function: protein binding; toxin transporter activity; Wnt receptor activity; Wnt-protein binding
Biological Process: bone marrow development; cholesterol homeostasis; glucose catabolic process; negative regulation of osteoblast differentiation; osteoblast development; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of mesenchymal cell proliferation; positive regulation of mitosis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of blood pressure; retina morphogenesis in camera-type eye; Wnt receptor signaling pathway; Wnt receptor signaling pathway through beta-catenin
Disease: Bone Mineral Density Quantitative Trait Locus 1; Endosteal Hyperostosis, Autosomal Dominant; Exudative Vitreoretinopathy 1; Exudative Vitreoretinopathy 4; Osteopetrosis, Autosomal Dominant 1; Osteoporosis; Osteoporosis-pseudoglioma Syndrome; Van Buchem Disease, Type 2
Research Articles on LRP5
1. A genetic evaluation of the known genes associated with familial exudative vitreoretinopathy (FEVR) revealed a novel variant in the LRP5 gene that co-segregated with the phenotype in the family.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.